ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

QTRX Quanterix Corporation

15.88
0.09 (0.57%)
Last Updated: 11:25:58
Delayed by 15 minutes

Period:

Draw Mode:

Volume 87,192
Bid Price 15.84
Ask Price 15.88
News -
Day High 16.33

Low
11.39

52 Week Range

High
29.70

Day Low 15.67
Company Name Stock Ticker Symbol Market Type
Quanterix Corporation QTRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.09 0.57% 15.88 11:25:58
Open Price Low Price High Price Close Price Prev Close
15.73 15.67 16.33 15.79
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,784 87,192 $ 15.92 $ 1,388,423 - 11.39 - 29.70
Last Trade Time Type Quantity Stock Price Currency
11:26:08 1 $ 15.8611 USD

Quanterix Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
602.17M 38.06M - 122.37M -32.33M -0.85 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Quanterix News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No QTRX Message Board. Create One! See More Posts on QTRX Message Board See More Message Board Posts

Historical QTRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week19.5319.7115.3316.61526,168-3.65-18.69%
1 Month24.0224.8715.3320.22407,044-8.14-33.89%
3 Months23.6329.7015.3323.45358,965-7.75-32.80%
6 Months19.7529.7015.3323.54347,942-3.87-19.59%
1 Year12.1129.7011.3922.98361,1043.7731.13%
3 Years60.1969.226.3124.36376,189-44.31-73.62%
5 Years21.8192.576.3128.92315,538-5.93-27.19%

Quanterix Description

Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum and other fluids which are undetectable using conventional, analog immunoassay technologies. The company has developed Simoa technology which is a method of detection of proteins and has the capability of analyzing nearly six biomarkers per test, with anticipated expansion capability.

Your Recent History

Delayed Upgrade Clock